Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02947165
Title Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups:
Covered Countries USA | ITA | DEU | CHE | CAN | AUT


No variant requirements are available.